Follow Us All RSS About Us

Message Boards

or

Twitter

or

Social Profile

Most popular: ALU BCRX CHK CHS F GE GLD GOOG HT IMGG KERX MSFT
  • StockTalk Live
  • OTC Live
  • ETFs Live
  • Forex Live
  • Top Searches
  • Twitter BuZZ
  • Web BuZZ

VNDA (Vanda Pharmaceuticals)

remove frame
Back to Search
« Prev Mesg
Next Mesg »
Tweet This

Yahoo! Finance

Re: Down 1/2 cent AH!!!!
Re: $10.9 in AH. With three million short this could get ugly!
Re: Whew!! enough...User drugstock@sbcglobal.net was added to your ignore list
Going for a Hike fo 5 miles....back
Re: PennyStockCoach's PLAYBOOK is FULL OF WINNERS FOR YOU!!!
Dont be a new bagholder.

ADFN InvestorsHub

Vanda Pharmaceuticals Reports Third Quarter 2009 Results
Details tomorrow.

Google Finance

eoquin very promising.......view this study link
Re: IS SPPI Jumping on the spot?
Re: IS SPPI Jumping on the spot?
New Pick to Fight Cancer: OTC: Entest BioMedical Inc
IS SPPI Jumping on the spot?

InvestorVillage

VNDA is the better buy, NOT Titan
Bought some shares today.....
Efficacy data looks good
Re: OMG!! Fanapt has black box for QT prolongation. And....?????
Re: OMG!! Fanapt has black box for QT prolongation. And....?????

ClearStation

out (Closing Long Recommendation)
Long (Long Recommendation)

FreeRealTime

HOW I MAKE $5,600 from a $67 INVESTMENT IN PENNYSTOCKS I...
SPPI is formerly NEOT.
All RSS

About BoardCentral | Contact | Advertise

© 1999-2008 BoardCentralTM Inc. All Rights Reserved. Privacy statement and Disclaimer

Privacy statement and Terms of Use. Questions, comments, suggestions or disputes – please contact us. All copyrights, trademarks and other intellectual property rights referred to on these pages belong to their respective owners. By using this site you are agreeing to our terms of use, and agree not to redistribute the information found therein. All information provided on this site is "as is" and provided for informational and entertainment purposes only, not intended for trading purposes and should not be considered as investment advice.